Siemens Healthineers Collaborates with National University Hospital to Enhance Non-Invasive Liver Disease Diagnostic Research
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 08 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Partnership Announcement: Siemens Healthineers and the National University Hospital (NUH) Singapore are collaborating to enhance diagnostic solutions for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), which affects nearly 40% of adults in Singapore.
Research Focus: The initiative will evaluate advanced ultrasound technologies, including Ultrasound-Derived Fat Fraction (UDFF) and Auto Point Shear Wave Elastography (Auto pSWE), to provide safer, non-invasive alternatives for liver disease diagnosis and monitoring.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
